24K views · 1K reactions | Johnson & Johnson announces that the World Health Organization has issued Emergency Use Listing for its single-shot COVID-19 vaccine developed by Janssen, marking an important step forward to ensuring global access. Read more: https://bit.ly/3ckfzhe | Johnson & Johnson | Facebook

JUST IN: A preclinical study published in Nature shows that Johnson & Johnson’s investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. According to the World Health Organization, as of July 2020, global cases have now surpassed 16 million. Learn more about the study’s findings and how J&J is harnessing its science, scale and expertise to help fight the pandemic. | Johnson & Johnson

2.1M views · 8.1K reactions | A preclinical study published in Nature about an investigational COVID-19 vaccine shows that it provides robust protection against the coronavirus. In this special episode, Lisa Ling talks to Johnson & Johnson’s Chief Scientific Officer Paul Stoffels, M.D. and Harvard’s Dan Barouch, M.D., Ph.D. about why these early results are encouraging. | Johnson & Johnson | Facebook